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Abstract
Introduction: The prevention and control of noncommunicable diseases (NCDs) are one of the main challenges of
healthcare systems around the world. In addition to the technical level, it requires political negotiations and
solutions, such as global health diplomacy (GHD), which involves the participation of a wide range of actors and
stakeholders and innovative international health partnerships. This review aimed to draw lessons for strengthening
linkages with a wide range of actors and stakeholders from the GHD literature for NCDs, and how policymakers and
political leaders can effectively use international health partnerships to beat NCDs.
Methods: This research was a systematic review of the literature on GHD for NCDs. All relevant articles published in
English were identified by searching PubMed, Web of Science, Scopus, and Embase databases, Google and Google
Scholar search engines, and the reference lists of identified articles as well as a number of special journals. 30
articles that met the inclusion criteria were analyzed using content analysis in MAXQDA 10. The Global Health
Diplomacy Pyramid and Blouin and Dubé’s (2010) analytical framework for examining negotiations were used to
classify the data.
Findings: 30 articles have been published on GHD for NCDs. Five key themes, i.e. the specific problem requiring
global collective action, key actors, their interests in the problem, potential negotiation process, and potential
scenarios for collective action and 46 sub-themes were identified. Moreover, given the importance of collaboration
on NCDs in the international arena, actors were categorized into three groups based on the GHD Pyramid: (1) core
diplomacy, (2) multi-stakeholder diplomacy, and (3) informal diplomacy.
Conclusion: Development and adoption of a global policy to tackle the rise in NCDs in developed and developing
countries require policymakers and political leaders that participate in GHD. Successful developments in global
health policy depend on the performance of and respectful relationships among the stakeholders, and global
health diplomats need to understand the complexities of the institutional structures and functional relationships of
the international institutions involved in health.
Keywords: Review [publication type], Diplomacy, Global Health, International cooperation, Noncommunicable
diseases, Policymaking
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Introduction
Over the last two decades, global health issues have be-
come more prominent in foreign policy. Events such as
the HIV/AIDS pandemic, infectious diseases, the threat
of bioterrorism, and issues related to trade and health
have prompted policymakers to focus more on health is-
sues [1–3]. As nations become more and more intercon-
nected and as health-related issues increasingly become
global issues, state actors in the domain of health are
forced to seek cross-border collective action and collab-
oration with nonstate actors [2, 4]. United Nations (UN)
General Assembly also emphasizes that governments
must pay more attention to global health in their foreign
policies and increase their negotiations and political in-
teractions in this field [5–7].
Global health diplomacy (GHD) is the process of ne-
gotiated collective action for global health that can even-
tually lead to new forms of global health policy and
governance [8]. This concept has received significant at-
tention from key global health actors, including the
World Health Organization (WHO), health and foreign
affairs ministries of countries, and academia [9–13].
Although GHD has entered the mainstream of coun-
tries’ foreign policy, it has different meanings, which
could generally be divided into three categories based on
the interaction of actors around global public health is-
sues: (1) core diplomacy, i.e. formal negotiations among
nations; (2) multi-stakeholder diplomacy, i.e. negotia-
tions among nations and other actors that do not neces-
sarily lead to agreements; and (3) informal diplomacy,
i.e. interactions between international public health ac-
tors and their counterparts, including host country offi-
cials, nongovernmental organizations, private companies,
and the public. Core and multi-stakeholder diplomacy in
global health require the effective use of a delicate mix
of technical expertise, legal knowledge, and diplomatic
skills [14]. A successful global health strategy for ad-
dressing public health and foreign policy goals requires
effective action at every level of the GHD pyramid, and
GHD, as practiced by health attachés, entails the identifi-
cation and engagement of key tools and actors as well as
coordinated action by various counterparts and stake-
holders [15].
Health diplomacy provides a political framework that
aims to improve health in target populations and en-
hance governmental relations between collaborating
countries. Governments offering health-related aid to a
nation with which they wish to develop stronger diplo-
matic links have the advantage of developing a deeper
relationship with its citizens [16]. This can be accom-
plished through different mechanisms such as providing
general funding, ensuring the supply of essential drugs,
investing in hospitals or equipment, and training health
professionals. Significant investments have been made in
Sub-Saharan Africa, South America, and South-East Asia
to eradicate specific diseases such as HIV/AIDS, malaria,
and tuberculosis. However, there has been relatively little
support for general health infrastructure, training, and
education, or the burden of chronic diseases in develop-
ing countries [17].
Each year, 41 million people die from noncommunic-
able diseases (NCDs), which is equivalent to 71% of all
deaths globally [18]. Evidence suggests the increasing
burden of NCDs in low and middle-income countries
(LMIC) [19, 20]. NCDs in LMIC account for 80% of
deaths and two-thirds of disabilities from NCDs world-
wide. More specifically, NCDs in LMIC mostly affects
people in their thirties, which is their most productive
working years and this is serious threat to health and
economic growth [21].
There is widespread international support for the fight
against NCDs. The UN High-Level Meeting on Preven-
tion and Control of NCDs [22], the WHO Global Action
Plan for the Prevention and Control of NCDs 2013–
2020 [23, 24], the WHO NCD Global Monitoring
Framework [25], and recognition of NCDs as a major
challenge to sustainable development [26] highlight this
issue. Although such support for prevention and control
of NCDs is encouraging, lack of international financing
for these efforts necessitates the development of multi-
stakeholder models to address the global burden of
NCDs.
Prevention and control of NCDs is one of the key
challenges of health systems that, in addition to a tech-
nical level, requires negotiations and political solutions
such as global health diplomacy (GHD), which involves
the participation of a wide range of actors and stake-
holders [27]. Policy interventions for health, prevention,
and control of NCDs must begin with diplomatic negoti-
ations between state officials [28]. Health threats such as
challenges to the safety of the global drug supply and
the spread of chronic and NCDsthat impact national
security increasingly highlight the need for diplomats
who understand health issues and can negotiate effect-
ively in the multinational foreign policy environment
[27–29]. Insufficient focus on NCDs by different sectors
at the national and international levels, including the
lack of funding for NCD research, prevention, and
control by governments and non-governmental organi-
zations (NGOs) necessitate the development of coordi-
nated strategies and diplomatic initiatives to address the
multinational nature of this issue [30]. GHD for NCDs is
defined as the process of negotiations by which state and
nonstate actors attempt to develop and implement col-
lective actions to solve global health challenges [1–4].
This paper argues that global health diplomacy and pol-
itical interactions and partnerships between policy actors
could contribute to a more effective global response and
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action to NCDs and leading to global health improve-
ments. The purpose of this review is to draw lessons
from the GHD literature for NCDs and how it can be ef-
fectively used by policymakers and political leaders.
Methods
This research ia a systematic review of the existing evi-
dence on GHD for NCDs, including cardiovascular dis-
eases, cancers, chronic respiratory diseases, and diabetes
as well as their risk factors, i.e. tobacco use, excess salt
and fat intake, alcohol abuse, and physical inactivity, in
the period 2007–2019. The second stage involved con-
tent analysis of the studies with a qualitative approach.
To find relevant articles for this review, PubMed, Web
of Science, Scopus, and Embase databases and Google
and Google Scholar search engines were used. Keywords
included MeSH and common terms related to the topic:
“Diplomacy” OR “Internationality” OR “foreign policy”
OR “foreign affairs” OR “international relations” OR
“international politics” OR “statesmanship” OR “state-
craft” OR “Health Diplomacy” OR “Medical Diplomacy”
OR “Negotiations” OR “Multilateral Engagement” OR
“Bilateral Agreements” AND “Drinking Behavior” “Alco-
holic Beverages” OR “Smoking” OR “Smokers” OR
“Feeding Behavior” OR “Diet” [MeSH] OR “Obesity” OR
“Food” OR “Fast Foods” OR “Sugars” OR “Sodium, Diet-
ary” OR “Exercise” [MeSH] OR “LifeStyle” OR “Healthy
Lifestyle” OR “Sedentary Behavior” OR “Alcohol Drink-
ing” [MeSH] OR “Tobacco Use” OR “Tobacco Products”
OR “Tobacco” OR “Noncommunicable Diseases”. More-
over, the reference lists of identified articles were manu-
ally searched to find more relevant studies. The studies
included in the qualitative synthesis include empirical
studies, commentaries and review articles. Inclusion
criteria for this study included literatures published in
English language and the year of publication included
studies published from 2007 to 2019 because initial
searches of the literature showed that most relevant
studies were conducted after 2007. Articles published in
any language other than English, articles that were not
unavailable in full text, dissertations, and redundant
studies were excluded.
Overall, 1895 articles were extracted. First, the title
and abstract of the articles were screened based on the
inclusion criteria and Studies which did not address the
research question and the duplicates of the same records
were then excluded in this stage and leaving 48 articles
for full-text review. 18 articles were excluded due to un-
availability in full-text form or redundancy, and 30 arti-
cles were selected for the final review. The screening
process and search results are provided in the PRISMA
flow diagram [31] (Fig. 1). Data were collected using a
data extraction form that was designed based on the ob-
jectives of the study. This form included entries on the
author, publication year, country, method of research,
key actors, content, context, Tools and main finding.
The remaining articles were entered into the quality
assessment stage. Quality was assessed independently by
two studies using the 15-point instrument of Mitton
et al. [32]. Each item is given a score of 0 (not present or
reported), 1 (present but low quality), 2 (present and
midrange quality), or 3 (present and high quality). Cri-
teria for quality assessment included: literature review
and identification of research gaps; research questions,
hypotheses, and design; population and sampling; data
collection process and instruments; and analysis and
reporting of results. Disagreements were resolved by dis-
cussion and, when essential, by consulting a third review
Fig. 1 PRISMA Flow Diagram: Database search and article selection process
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author. Given that the review was qualitative, articles
were not removed at this stage, but more weight was
given to articles with a quality rating of 10 or above in
the data analysis and interpretation of results.
Then, a content analysis of the articles was performed.
The data were coded and managed using MAXQDA 10
for Windows (VERBI GmbH, Berlin, Germany), and re-
lated themes and sub-themes for each article were ex-
tracted to identify the relationships among these themes
and identify patterns and meanings. The GHD Pyramid
[14, 15] and the Negotiations Review Analytical Frame-
work [4] were used to classify the data.
Results
Between 2007 and 2019, 30 articles have been published
on GHD for NCDs (Table 1). About 57% of the articles
have been published since 2016, with the majority of
studies (10 articles) published in 2018 (Fig. 2). Trends
suggest that the number of articles has increased around
2011 and 2018 in which the UN General Assembly held
high-level meetings on the prevention and control of
NCDs.
In Table 2, five themes are identified using the Blouin
and Dubé’s (2010) analytical framework for examining
negotiations: (1) the specific problem requiring global
collective action, (2) key actors, (3) their interests in the
problem, (4) potential negotiation process, and (5)
potential scenarios for collective action. Besides, 46 sub-
themes related to GHD on NCDs are identified
(Table 2).
Given the importance of mapping actors, their inter-
ests, and structural characteristics related to them, inter-
actions in the international arena on NCDs are divided
into three categories using the GHD Pyramid: (1) core
diplomacy, (2) multi-stakeholder diplomacy, and (3) in-
formal diplomacy. Actors, tools, contents, and contexts
were extracted at each of these three levels (Table 3).
The key actors are identified at different levels of dip-
lomacy: Core diplomacy: UN and associated agencies
and groups, including the WHO and the Independent
High-level Commission on NCDs, heads of government,
international professional associations, International Dia-
betes Federation, Union for International Cancer Con-
trol, and World Heart Federation; Multi-stakeholder
diplomacy: Asia-Pacific Economic Cooperation (APEC),
national governments and ministries (e.g. health, foreign
policy, education, finance, labor, etc.), commercial actors
(e.g. pharmaceutical companies, a variety of businesses
involved in the production, processing, distribution,
marketing, and sales of food and beverages), civil society
organizations and coalitions (e.g. Nutrition Foundation,
National Center for Chronic Disease Prevention, Na-
tional Cancer Institute), healthcare regulatory agencies,
Parliamentary Committee for Prevention and Control of
NCDs, and National Inter-ministerial Tobacco Control
Committee; Informal diplomacy: NCD Alliance (NCDA),
Framework Convention on Tobacco Control (FCTC),
and Union for International Cancer Control, research
centers, the academia, the medical community, the pri-
vate sector, patients and their families, international
donors, and health advocacy groups, NGOs, and hu-
manitarian organizations.
Critical information are discussed in the content of
some declaration and agreement for raising global chal-
lenges to GHD and negotiation (Table 3). For example
The Paris Declaration on Aid Effectiveness has a leading
role in raising awareness of climate change on the inter-
national stage and advocating for strong climate action
for new global challenges such as rising food and climate
change and Port of Spain Summit Declaration helped to
rise NCDs agenda in global setting.
Discussion
The purpose of this Systematic review was to draw les-
sons for strengthenning linkages with a wide range of
actors and stakeholders from the GHD literature regard-
ing the prevention and control of NCDs. GHD is fo-
cused on international negotiation that includes a wide
range of processes, from finalizing agreements between
multilateral or bilateral aid donors and recipient coun-
tries to the processes of making binding and non-
binding international agreements in health or related to
health. Between 2007 and 2019, 30 articles have been
published on GHD for NCDs.
Five themes, i.e. (1) the specific problem requiring glo-
bal collective action, (2) key actors, (3) their interests in
the problem, (4) potential negotiation process, and (5)
potential scenarios for collective action and 41 sub-
themes on GHD in prevention and control of NCDs
were identified. Moreover, given the importance of col-
laboration on NCDs in the international arena, actors
were categorized into three groups based on the GHD
Pyramid: (1) core diplomacy, (2) multi-stakeholder dip-
lomacy, and (3) informal diplomacy.
Seven specific problems that require global collective
action were identified: the globalization of marketing
and advertising strategies, sanctions, multinational com-
panies undermining the regulatory authority of national
governments, the need for stronger engagement with de-
veloping countries for GHD on obesity and tobacco con-
trol, current migration and travel patterns, trafficking,
and trade liberalization. International commitments have
changed the dynamics of countries’ domestic policies.
For example, multinational tobacco companies under-
mine the regulatory authority of national governments
through public relations and lobbying strategies [61].
Due to the asymmetry of resources between large global
tobacco firms and the governments of small countries,
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Table 1 Characteristics of studies on GHD for NCDs
Author Country/
Region
Year Journal Level of
Diplomacy
Domain article type Method key findings
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Table 1 Characteristics of studies on GHD for NCDs (Continued)
Author Country/
Region
Year Journal Level of
Diplomacy
Domain article type Method key findings
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Table 1 Characteristics of studies on GHD for NCDs (Continued)
Author Country/
Region
Year Journal Level of
Diplomacy
Domain article type Method key findings
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Table 1 Characteristics of studies on GHD for NCDs (Continued)
Author Country/
Region
Year Journal Level of
Diplomacy
Domain article type Method key findings
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this problem is specifically acute in developing countries
[36]. The adoption and implementation of tobacco con-
trol measures have strengthened the position of public
health advocates against pressure from multinational
tobacco companies [36].
One of the lessons learned from tobacco control is the
need to focus on the upstream factors in the NCD pan-
demics such as multinational companies and globalized
advertising and promotion of unhealthy products. To-
bacco control activity at the global level is affected by
the actions of the tobacco industry, increasing
globalization of aggressive marketing, and changing so-
cial norms regarding smoking. As a result, it is difficult
for any country to control tobacco use within its borders
and a collective response is necessary. Policies focused
on increasing price, decreasing access, restricting
Table 1 Characteristics of studies on GHD for NCDs (Continued)
Author Country/
Region
Year Journal Level of
Diplomacy
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advertising and improving labeling could be applied to
products that promote NCDs, especially alcohol and
processed foods that are high in sugar and fat [41].
The complexity and costs associated with effective
management of NCDs require the involvement of a di-
verse group of actors. Given the increased pressure faced
by developing countries with unprepared systems and
economies, diverse partnerships may be a more import-
ant component in effective prevention and management
of NCDs [30]. GHD researchers have studied inter-
national negotiations as a “two-level game” at national
and international levels. At the international level,
governments seek to maximize their ability to meet do-
mestic pressures, while minimizing the negative conse-
quences of foreign development. At the national level,
domestic groups pressure the government to adopt fa-
vorable policies for their interests, and politicians seek
power by building coalitions among those groups [62].
There is power asymmetry in international negotiations.
This is exacerbated in the context of NCDs and GHD
since health ministries and agencies are often less
powerful within their governments. Two strategies to
overcome this challenge are building coalitions and
preparing for negotiation [30].
Governments must be the key stakeholders in policy
development and provide leadership for implementation,
monitoring, and evaluation through a multi-stakeholder
platform. The government may decide to cooperate with
other sectors and stakeholders, but it is in the best pos-
ition to set the direction and overall strategy for achiev-
ing public health goals [63]. There are differing views
within the government about the specific positions and
strategies the country should take during negotiations.
Creating an inter-ministerial committee is a useful way
of using these different perspectives in international ne-
gotiations. The history of health-related trade negotia-
tions indicates the importance of these institutional
mechanisms for intersectoral collaboration [64]. After
setting a clear negotiating agenda at the national level,
the most conventional form of GHD takes place, i.e. for-
mal negotiations between parties. In international nego-
tiations, parties with different preferences need to
exchange concessions. One party concedes to the prefer-
ences of the other party and, in exchange, ensures that
its priority is reflected in the final text. In these negotia-
tions, building coalitions with like-minded parties is a
useful strategy for smaller countries that seek to achieve
their objectives [30].
In the context of NCDs, a key aspect of GHD is
the variety of nonstate actors that must be engaged
with at different parts of the process, and it is crucial
to understand the incentives of these actors pertain-
ing to the costs and benefits of participation [34, 65,
66]. Civil society organizations must be involved in
international negotiations on public health issues and
must focus on providing and sharing relevant scien-
tific information with national delegates. All the dele-
gates and FCA participants in the FCTC argued that,
at the beginning of the Intergovernmental Negotiating
Body (INB) sessions, there were significant differences
in the knowledge of national delegates of tobacco use
and tobacco control. The FCA has helped close this
gap by providing and sharing information with the
delegates [37]. It is the actors involved in a negoti-
ation process that determine whether to place an
issue on the national and international agenda and
whether to create alternatives for its effectiveness. It
is thus necessary for NCD stakeholders to come
Fig. 2 Frequency distribution of studies on GHD for NCDs
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Table 2 Analytical framework for examining negotiations
Themes Subthemes
(1) The specific problem requiring global
collective action
- Globalization of marketing and advertising strategies
- Sanctions, including financial, travel and trade restrictions
- Multinational companies undermining the regulatory authority of national governments through public
relations and lobbying strategies, and the need to develop coordinated strategies and diplomatic
initiatives to address the multinational nature of the problem
- GHD on obesity and tobacco control requires stronger engagement with developing countries
- The need for collective action against NCDs given the current migration and travel patterns
- Smuggling
- Trade liberalization, including a reduction in trade barriers and prices to increase competition in the
international market
- New global challenges such as climate change
(2) Key actors - United Nations and associated agencies and groups, including the WHO and the Independent High-level
Commission on NCDs, and groups and important political clubs such as G7, G8/ BRICS
- the Food and Agricultural Organisation (FAO)
- the World Bank
- the World Trade Organisation (WTO)
- the Codex Alimentarius Commission
- Heads of government
- National governments and ministries (e.g. health, foreign policy, education, finance, labor, etc.)
- Regional coalitions of countries
- International Diabetes Federation
- World Heart Federation
- Asia-Pacific Economic Cooperation (APEC)
- Health advocacy groups, NGOs, and humanitarian organizations
- International professional associations
- Commercial actors (e.g. pharmaceutical companies, a variety of businesses involved in the production,
processing, distribution, marketing, and sales of food and beverage)
- Civil society organizations and coalitions (e.g. Nutrition Foundation, National Center for Chronic Disease
Prevention, National Cancer Institute)
- Healthcare regulatory agencies
- Parliamentary Committee for Prevention and Control of NCDs
- National Inter-ministerial Tobacco Control Committee
- NCD Alliance, Framework Convention on Tobacco Control, and Union for International Cancer Control
- Research centers and the academia
- The medical community
- The private sector
- Patients and their families
- International donors
(3) Actors’ interests in the problem - UN and WHO: technical support, non-binding recommendations and policy advice, international legal
obligations and laws, advocacy
- Groups and political clubs such as G7, G8/ BRICS: Supporting reforms, develop framwork for regulation,
support growth and development across globe, Strengthen international cooperation
- Governmental actors: governments represent power in diplomacy, while NGOs represent ideas and
knowledge
- NGOs: monitoring, lobbying, brokering knowledge, offering technical expertise, and fostering inclusion;
NGOs act as a catalyst to the process of developing policies and drive it by including stakeholders,
offering technical expertise, and providing financial assistance; multisectoral partnerships aimed at
capacity-building and strengthening health systems
- Industrial actors: reduced market share and profits due to measures to limit tobacco use
- Unions: advocacy of NCD Alliance to trigger a global policy response, the role of Framework Convention
Alliance (FCA) in agenda-setting for tobacco control
- Policy champions: strong supportive role
(4) Potential negotiation process - Scientific and technical capacity building
- Preparation for negotiations, mobilization of civil society organizations, dialogue with industry,
consultation with experts, and sharing of information among national health agencies
- Entering the negotiating forum
- Monitoring, lobbying, brokering knowledge, offering technical expertise, and fostering inclusion
(5) Potential scenarios for collective
action
- Drawing attention to issues that are not yet on the GHD agenda or are largely overlooked
- Political leadership, strong mobilization, and advocacy from well-organized groups globally are crucial in
triggering and sustaining a global policy response such as an international treaty
- A monitoring role that involves publicizing the diplomatic process
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Table 3 Prevention and control of NCDs at different levels of the GHD Pyramid
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together within and among countries to advocate for
their needs and priorities [21].
Six key sub-themes were identified for the theme “ac-
tors’ interests in the problem”. WHO recommendations
are non-binding, but represent the organization’s official
policy and reflect its norms and standards. Moreover,
these recommendations indicate successful GHD. How-
ever, successful international agreements are not always
implemented at a national level, and thus, they may not
bring about the desired health benefits [40]. A weakness
of the UN Declaration on the High-Level Meeting on
NCDs in September 16, 2011, is that it was lacking in
targets, funds, and activities. An important determinant
in the relatively weak outcome of this exercise in GHD
is the weak presence of advocacy groups and activists re-
garding NCDs. An important lesson from successful
GHD in the past is the key role of civil society organiza-
tions in ensuring a strong collective response. This fac-
tor was critical to the success of FCTC negotiations [46].
It is necessary to strengthen governance and coordin-
ation structures across different sectors and levels to en-
sure that all relevant sectors are involved in NCD
prevention measures. Countries must use a strong advo-
cacy and communications strategy on multi-sectoral ac-
tion for NCD prevention in order to increase NCD
awareness among various sectors and resolve conflicts.
Sustainable joint financing mechanisms are needed for
the effective implementation of these actions. In
addition, countermeasures must be employed to prevent
industries from obstructing the implementation of NCD
prevention measures [42]. Conflict of interest can hinder
or halt policy development or participation of different
sectors. One of the negative effects of actors’ interests is
industry interference with the process of policy develop-
ment and implementation, especially the tobacco
industry, which has interfered with the policy process in
almost every country in LMIC. Market forces contribute
to an increase in NCDs. For example, pandemics related
to obesity and tobacco and alcohol use are mainly due
to the successful marketing of unhealthy products. This
outcome is a serious justification for government inter-
vention through regulatory and legal responses.
NCD control requires political champions for advo-
cacy. The most important outcome of the new diplo-
matic attention to NCDs is the platform provided for
greater coordination on NCDs among the UN, national
governments, and civil society. One of the key challenges
in NCD prevention and control is the complexity of
these diseases, as they are caused by a variety of risk fac-
tors and are associated with various agents, from the
international level (e.g. multinational fast food compan-
ies) to the local level (e.g. unwalkable streets). In
addition, not all NCDs are preventable. Due to these
complexities, it is difficult to specify their targets and
funds. The global response to NCDs must focus on gen-
erating multisectoral evidence about the transnational
factors that contribute to the rise in NCDs and the po-
tential impact of policies proposed to control them [41].
As for the theme “the potential negotiation process”,
four sub-themes were identified, including scientific and
technical capacity building, preparation for negotiation,
entering the negotiating forum, and monitoring, lobby-
ing, brokering knowledge, offering technical expertise,
and fostering inclusion. GHD is a political process based
on the intersection of health, foreign policy, and trade
that can take place at bilateral and multilateral levels
through political negotiations [66, 67].
Therefore, it is first necessary to strengthen the scien-
tific and technical capacities of health attachés and de-
velop diplomats for the GHD platform. Preparation for
Table 3 Prevention and control of NCDs at different levels of the GHD Pyramid (Continued)
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alcohol and tobacco use
- National Campaign for
Tobacco Control and
Smoking Cessation
- Specific activities such as
games for the elderly
- World No Tobacco Day
- NCD Advocacy Document - Understanding the historical context of
negotiations
- Any country is several markets rather than one,
with a wide variety of marketing types
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negotiations by mobilization of civil society organiza-
tions, dialogue with industry, consultation with experts,
and sharing of information among national health agen-
cies are crucial steps before entering negotiations [36].
Moreover, to address many global public health issues in
which some countries put political expediencies and
their interests above collective global interests, one strat-
egy is to hold countries accountable by publicizing their
positions and reward positions that support a strong
treaty [37]. GHD always takes place through national
politics. Therefore, the successful conclusion of inter-
national negotiations is not the end, but part of a
process and GHD must be conducted and evaluated by
considering the barriers and issues concerning national
action [40].
Three sub-themes were identified for the theme “po-
tential scenarios for collective action”: First scenario:
Drawing attention to issues that are not yet on the GHD
agenda or are largely overlooked. GHD is the process of
negotiated collective action for global health that can
eventually lead to new forms of global health policy and
governance for tackling global health challenges. It is
clear that the development of national policies and
FCTC negotiations have clearly interacted. Once Canada
adopted large graphic health warnings, Thailand, Brazil,
and the European Union followed suit [68]. Until re-
cently, the field of GHD on NCDs was primarily WHO-
centric. A key challenge was to bring NCDs beyond the
traditional health forum and that is why the UN High-
Level Meeting is regarded as a great opportunity. When
deciding to engage in GHD for a problem identified dur-
ing the agenda-setting phase, an important consideration
for policymakers is the impact of the media on the polit-
ical agenda. The media is deemed to play a greater role
in putting issues on the foreign policy agenda than the
domestic policy agenda [69].
Second scenario: Political leadership, strong
mobilization, and advocacy from well-organized groups
globally are crucial in triggering and sustaining a global
policy response such as an international treaty. Success
in tackling the NCD crisis depends on strong and ef-
fective leadership. A strong leader can act as a catalyst
and bring about change [70]. Moreover, NGOs and civil
society have provided significant support for policy de-
velopment and the interaction of various actors. NGOs
can act as a catalyst to trigger the policy process and
drive this process by coordinating the entry of stake-
holders, offering technical support, and providing fi-
nancial assistance. In addition, coalitions and networks
may be formed ton ensure that implementation of
certain policies will continue. These networks tend to
engage various sectors in this process. Professional
associations can also become part of advocacy and
coalition networks [41].
Third scenario: A monitoring role that involves publi-
cizing the diplomatic process, such as exposing the pos-
ition of countries in documents distributed to diplomats
and on the Internet for the general public. There is an
established Monitoring and Evaluation for Port of Spain
declaration which is robust and no other NCD policy
has such a mechanism on a periodic basis. Monitoring
of the Declaration was cunducted by CARICOM and the
Pan American Health Organization (PAHO) and evalu-
ating was cunducted by the University of the West In-
dies [67, 71].There is an urgent need for advocacy to
raise NCD awareness at the national and international
levels as a development problem, not just a health prob-
lem. In addition, increasing the capacity for policy re-
search and implementation is needed in all countries
[46].
Conclusion
This paper has highlighted the role of global health dip-
lomacy in all three levels for preventing and controlling
of NCDs. There is an urgent need for advocacy to raise
NCD awareness at the national and international levels
as a development problem, not just a health problem. In
addition, increasing the capacity for policy research and
implementation is needed in all countries. The develop-
ment and adoption of a global policy to tackle the rise in
chronic diseases in developing and developed countries
requires policymakers that engage in GHD. Successful
developments in global health policy depend on the per-
formance and respectful relationships of stakeholders,
and global health diplomats need to have an understand-
ing of the complexities of institutional structures and
the functional relationships among international institu-
tions involved in health. A successful and sustainable
plan for tacking NCDs entails partnerships among na-
tional governments, the private sector, and civil society
at international, national, and local levels.
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